Benitec Biopharma Ltd ADR (BNTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2019 | 09-2019 | 06-2019 | 12-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -1,147 | 2,609 | N/A | -9,025 |
| Depreciation Amortization | N/A | 51 | 158 | N/A | 150 |
| Accounts receivable | N/A | 974 | 607 | N/A | 56 |
| Accounts payable and accrued liabilities | N/A | -645 | 740 | N/A | 976 |
| Other Working Capital | N/A | 450 | 1,323 | N/A | 920 |
| Other Operating Activity | -3,544 | -228 | -647 | 6,232 | -671 |
| Operating Cash Flow | $-3,544 | $-545 | $4,790 | $6,232 | $-7,593 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -79 | 1 | -400 | -42 | -63 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -51 |
| Investing Cash Flow | $-79 | $1 | $-400 | $-42 | $-114 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,278 | 2,250 | N/A | N/A | 6,838 |
| Other Financing Activity | -581 | -480 | 0 | 0 | -243 |
| Financing Cash Flow | $1,697 | $1,770 | $N/A | $N/A | $6,596 |
| Exchange Rate Effect | 43 | -313 | -551 | 911 | 112 |
| Beginning Cash Position | 15,329 | 15,718 | 11,879 | 16,085 | 13,471 |
| End Cash Position | 13,446 | 16,631 | 15,718 | 23,186 | 12,471 |
| Net Cash Flow | $-1,883 | $913 | $3,839 | $7,101 | $-1,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,544 | -545 | 4,790 | 6,232 | -7,593 |
| Capital Expenditure | -80 | N/A | -404 | -42 | -64 |
| Free Cash Flow | -3,624 | -545 | 4,386 | 6,190 | -7,658 |